✦ LIBER ✦

866 Combination of doxorubicin/ifosfamide ± G-CSF in adult metastatic soft tissue sarcoma (STS)

✍ Scribed by H.J. Weh; M. de Wit; D.K. Hossfeld

Book ID: 116167612
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 313 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)96115-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose ifosfamide, doxorubicin, dacar

High dose ifosfamide, doxorubicin, dacarbazine and G-CSF for patients with metastatic or locally advanced soft tissue sarcoma

✍ Lin Tong-yu; Guang Zhong-zhen; Su Yi-sun; Zhou Zhong-mei; Liu Dong-geng 📂 Article 📅 1999 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 357 KB

Doxorubicin plus ifosfamide with rhGM-CS

Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group

✍ W. P. Steward; J. Verweij; R. Somers; G. Blackledge; M. Clavel; A. T. Van Ooster 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 561 KB

Treatment of advanced soft tissue sarcom

Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy

✍ Bari?ta, ?brah??m; Tekuzman, G�lten; Yal�in, ?uay??b; G�ll�, ?brah??m; G�ler, N? 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas. Forty consecutive patients with a median age of 35.5 years were treated. Ifosfamide was administered at a dose of 2.5 g/m 2 /day as 72-hour con

A phase I–II study of ifosfamide in comb

A phase I–II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma

✍ Mansi, Janine L.; Fisher, Cyril; Wiltshaw, Eve; Macmillan, Sheila; King, Michael 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 433 KB

855 The use of R-met Hu 6-CSF in combina

855 The use of R-met Hu 6-CSF in combination with high and standard doses of Ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma

✍ M. Erkisi; E. Erkurt; S. Ozbarlas; R. Burgut; F. Doran; E. Seyrek 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Phase 1 European Organisation for Resear

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas

✍ O.S. Nielsen; P. Reichardt; T.B. Christensen; D. Pink; S. Daugaard; C. Hermans; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB